Nasal spray flu vaccine for adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests a flu vaccine given as a nasal spray instead of a shot. It aims to see how well it protects adults aged 18 to 59 from getting the flu.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old.
- You have not had a flu vaccine in the last 6 months.
- You have not had the flu in the last 6 months.
- You do not have a fever (>37.0°C) on the day of vaccination.
- You are not allergic to eggs or other vaccine ingredients.
- You do not have a weakened immune system or take immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how healthy adults respond to the nasal flu vaccine (FluMist). It aims to understand immune responses and may help improve future flu vaccines.
This trial tests an experimental flu shot that includes an adjuvant (an ingredient that boosts the immune response). It aims to see if the shot is safe and how well it works in adults. Participation lasts for a few months and involves blood tests and a review of any side effects.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This study tests a new flu vaccine to see how well it protects adults aged 18 to 64. If you join, you'll get the vaccine and have some check-ups to see how your body responds.
Hear when a new Prevention of Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.